Literature DB >> 30804161

Sentinel bruising as a presentation of metastatic melanoma.

Lloyd Steele1,2, Chit Cheng Yeoh3.   

Abstract

A 46-year-old man presented with a 4-week history of bruising with subcutaneous nodules and weight loss. He also had a 2-week history of progressive back and hip pain. He had been diagnosed with stage Ib cutaneous melanoma 30 months previously, which had been fully excised. A sentinel lymph node biopsy was negative. On examination, there were five skin lesions at different stages. Each had spontaneously appeared as a bruise with a central subcutaneous nodule, and the bruising then faded to leave a persistent subcutaneous nodule. Excision of one of the nodules demonstrated a 4.5 mm diameter partly necrotic melanoma deposit in the dermis. CT scan of the head, chest, abdomen and pelvis showed widespread metastases. This rare presentation of cutaneous malignant melanoma metastases has been termed 'sentinel bruising'. There are fewer than 10 cases reported in the literature. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dermatology; oncology; skin cancer

Mesh:

Year:  2019        PMID: 30804161      PMCID: PMC6388787          DOI: 10.1136/bcr-2018-228114

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Hematoma-like metastases.

Authors:  Thomas Jouary; Michele Delaunay; Alain Taieb
Journal:  J Am Acad Dermatol       Date:  2006-12       Impact factor: 11.527

2.  A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses.

Authors:  William Kelly Dehart; Anita C Gilliam; Kurt Q Lu; Joanna Brell
Journal:  Arch Dermatol       Date:  2008-04

Review 3.  Metastatic pathways in patients with cutaneous melanoma.

Authors:  Nikki R Adler; Andrew Haydon; Catriona A McLean; John W Kelly; Victoria J Mar
Journal:  Pigment Cell Melanoma Res       Date:  2016-11-30       Impact factor: 4.693

4.  Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.

Authors:  Laura K Ferris; Aaron S Farberg; Brooke Middlebrook; Clare E Johnson; Natalie Lassen; Kristen M Oelschlager; Derek J Maetzold; Robert W Cook; Darrell S Rigel; Pedram Gerami
Journal:  J Am Acad Dermatol       Date:  2017-01-19       Impact factor: 11.527

5.  Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site.

Authors:  E de Vries; T E C Nijsten; O Visser; E Bastiaannet; S van Hattem; M L Janssen-Heijnen; J-W W Coebergh
Journal:  Ann Oncol       Date:  2007-10-31       Impact factor: 32.976

6.  Hematoma-like metastasis in melanoma.

Authors:  László Török; Agnes Kirschner; Henriette Ocsai; Kitti Olasz
Journal:  J Am Acad Dermatol       Date:  2003-11       Impact factor: 11.527

Review 7.  Metastatic colonization by circulating tumour cells.

Authors:  Joan Massagué; Anna C Obenauf
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

8.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

9.  Resolution of Cullen's sign in patient with metastatic melanoma responding to hypoxia-activated prodrug TH-302.

Authors:  Glen J Weiss; Karen Lewandowski; Jon Oneall; Stew Kroll
Journal:  Dermatol Reports       Date:  2011-12-01

Review 10.  Melanoma epidemiology, biology and prognosis.

Authors:  Z Ali; N Yousaf; J Larkin
Journal:  EJC Suppl       Date:  2013-09
View more
  1 in total

1.  High Hemin Concentration Induces Escape from Senescence of Normoxic and Hypoxic Colon Cancer Cells.

Authors:  Agata Borkowska; Aleksandra Olszewska; Weronika Skarzynska; Marta Marciniak; Maciej Skrzeszewski; Claudine Kieda; Halina Was
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.